Valuation DexCom, Inc. Mexican S.E.
Stocks
DXCM *
US2521311074
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Mexican S.E.
2026-09-22
|
5-day change | 1st Jan Change | ||
| 1,536.29 MXN | +0.48% |
|
+0.48% | +26.65% |
| 05:46am | Tandem Diabetes Expands Insulin Delivery System to 12 New Countries | MT |
| 09-17 | Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 32,687 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 26.28% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 31,926 | 31,626 | 30,810 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 21.81% | -0.94% | -2.58% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 34.7x | 29.2x | 24.1x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.5x | 9.58x | 7.38x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.5x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.25x | 5.64x | 5.06x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 6.1x | 5.45x | 4.77x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 19.2x | 16.5x | 13.9x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 25.6x | 21.9x | 17.9x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 31.3x | 25.9x | 21x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.2% | 3.86% | 4.77% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.495 | 2.969 | 3.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,921 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,447 | 1,722 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 86.62 | 86.62 | 86.62 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.7x | 3.97x | 15.34x | 2.54% | 175B | |
| 18.75x | 3.44x | 12.31x | 3.18% | 113B | |
| 16.81x | 0.2x | 12.34x | 0.77% | 58.57B | |
| 35.42x | 3.42x | 11.72x | 2.13% | 50.07B | |
| 28.64x | 7.07x | 18.26x | 1.4% | 49.92B | |
| 34.72x | 6.1x | 19.16x | -.--% | 32.69B | |
| 45.51x | 1.29x | 11.97x | 0.21% | 30.44B | |
| 43.2x | 7.58x | 27.18x | 0.24% | 26.07B | |
| 54.38x | 7.25x | 23.3x | 0.39% | 23.55B | |
| Average | 34.01x | 4.48x | 16.84x | 1.21% | 62.22B | |
| Weighted average by Cap. | 29.06x | 3.98x | 15.27x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DXCM * Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
